Antifungal Susceptibility Patterns in Candida Spp. Isolated From Vaginal Swabs of Pregnant Women in Iraq

Authors

  • Mhmood Abed Hamzah Ministry of Education, Al-Karkh 3
  • Azhar Said Hendal Open Educational College
  • Faiza Jabbar Joda Ministry of Education, Open College of Education, Iraq
  • Saif Mazeel Abed Ministry of Health, Al-Muthana Health Directorate

DOI:

https://doi.org/10.51699/cajotas.v7i2.1672

Keywords:

Antifungal Susceptibility, H.V.S, Candida spp, Pregnant Women

Abstract

Vulvovaginal infections are one of the most important health issues faced by women of reproductive age. Most of the cases are caused by bacteria and fungi Candida albicans. The purpose of the study is to monitor the demographic pattern of vaginal infections in pregnant women and check the susceptibility of fungi against antifungal agents, which is of great concern in today’s world with increasing drug resistance. One hundred vaginal swabs were collected from pregnant women in different areas of different cities, and the women were distributed in different age groups. The isolates were identified, and 30 fungal isolates of Candida albicans were subjected to antifungal susceptibility testing with antifungal agents such as clotrimazole, amphotericin B, nystatin, itraconazole, fluconazole, and caspofengin. MDR is the ability of an isolate to resist three or more of the most commonly used agents. The most important part of the study is the prevalence rate, which is 60% in the case of bacterial infections and 40% in the case of fungal infections. Demographic distribution: The highest affected groups were between the ages of 31-40, followed by the 18-30 age group, while the least affected were in the 41-60 age group. It was noted that the rural population was the highest affected by the disease. Clotrimazole and Amphotericin B had the highest sensitivity rates of 33.3%. Nystatin had an average effect of (26.7%), while Itraconazole had the least effectiveness of (3.3%), results showed total resistance (100%) to fluconazole and caspofengin. All Candida samples were resistant to three or more drugs, thus classified as multidrug-resistant.

Downloads

Download data is not yet available.

References

A. Arastehfar et al., “Drug resistant fungi: An emerging challenge threatening our limited antifungal armamentarium,” Antimicrobial Agents and Chemotherapy, vol. 64, no. 4, e01923-19, 2020.

F. Bongomin, S. Gago, R. O. Oladele, and D. W. Denning, “Global and multi-national prevalence of fungal diseases—estimate precision,” Journal of Fungi, vol. 3, no. 4, p. 57, 2017.

M. A. Pfaller and D. J. Diekema, “Epidemiology of invasive candidiasis: A persistent public health problem,” Clinical Microbiology Reviews, vol. 23, no. 1, pp. 161–182, 2010.

S. G. Whaley, P. D. Rogers, and E. L. Berkow, “Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species,” Frontiers in Microbiology, vol. 7, p. 2173, 2017.

P. Bhattacharjee, “Epidemiology and antifungal resistance in Candida species,” Current Fungal Infection Reports, vol. 10, no. 2, pp. 67–75, 2016.

D. S. Perlin, “Echinocandin resistance in Candida,” Clinical Infectious Diseases, vol. 61, suppl. 6, pp. S612–S617, 2015.

J. de C. Orlandi Sardi et al., “Vulvovaginal candidiasis: Epidemiology and risk factors, pathogenesis, resistance, and new therapeutic options,” Current Fungal Infection Reports, vol. 15, pp. 32–40, 2021.

V. Sustr, P. Foessleitner, H. Kiss, and A. Farr, “Vulvovaginal candidosis: Current concepts, challenges and perspectives,” Journal of Fungi, vol. 6, no. 4, p. 267, 2020.

A. N. M. Gubran, M. A. A. Al Baghdadi, and N. M. Al Haidary, “Vulvovaginal candidiasis and antifungal susceptibility pattern of isolated Candida spp. among women in Aden Governorate, Yemen,” BMC Infectious Diseases, vol. 26, no. 1, p. 232, 2026.

“Vulvovaginal candidiasis: A global perspective through systematic review and meta-analysis,” Journal Name, vol. x, no. x, pp. xx–xx, 2026.

X. Zeng, Y. Zhang, T. Zhang, Y. Xue, H. Xu, and R. An, “Risk factors of vulvovaginal candidiasis among women of reproductive age,” Mycopathologia, vol. 183, no. 3, pp. 651–657, 2018.

R. Zaman, I. Ullah, and A. Arif, “Antifungal resistance in Candida species isolated from patients presenting with vulvovaginal candidiasis during different trimesters of pregnancy,” Journal of Population Therapeutics and Clinical Pharmacology, year unknown.

S. Sasi et al., “Recurrent vulvovaginal candidiasis caused by fluconazole resistant Candida albicans: A retrospective study,” Cureus, vol. 17, no. 2, e78906, 2025.

B. K. Sahu et al., “Genetic diversity and antifungal resistance in Candida albicans from VVC cases in Indian women,” BMC Microbiology, vol. 25, p. 535, 2025.

D. Yadav et al., “Fluconazole resistant vulvovaginal candidiasis in reproductive age women: A study from Himalayan country,” BMC Microbiology, vol. 25, p. 656, 2025.

J. D. Sobel, “Vulvovaginal candidosis,” The Lancet, vol. 369, no. 9577, pp. 1961–1971, 2007.

A. Bitew and Y. Abebaw, “Vulvovaginal candidiasis: Species distribution and antifungal susceptibility pattern of Candida isolates among symptomatic women in Ethiopia,” BMC Infectious Diseases, vol. 18, p. 161, 2018.

M. Khan, J. Ahmad, and M. S. Khan, “Prevalence of Candida species and antifungal susceptibility patterns in clinical isolates,” Journal of Mycology and Medical Microbiology, vol. 30, no. 2, p. 100908, 2020.

B. Sahoo, S. Mohanty, and P. Parida, “Prevalence of vulvovaginal candidiasis among sexually active females attending a tertiary care hospital,” International Journal of Clinical and Biomedical Research, vol. 4, no. 3, pp. 25–29, 2018.

M. Abdul Aziz et al., “Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive aged women in Sana’a city, Yemen,” BMC Infectious Diseases, vol. 19, p. 879, 2019.

C. F. Rodrigues, S. Silva, and M. Henriques, “Candida glabrata: A review of its features and resistance,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 38, no. 2, pp. 211–221, 2019.

D. Sanglard, “Emerging threats in antifungal resistant fungal pathogens,” Frontiers in Medicine, vol. 3, p. 11, 2016.

Downloads

Published

2026-04-07

How to Cite

Hamzah, M. A. ., Hendal, A. S. ., Joda, F. J. ., & Abed, S. M. . (2026). Antifungal Susceptibility Patterns in Candida Spp. Isolated From Vaginal Swabs of Pregnant Women in Iraq. Central Asian Journal of Theoretical and Applied Science, 7(2), 108–113. https://doi.org/10.51699/cajotas.v7i2.1672

Issue

Section

Articles